Quote | SPDR S&P International Mid Cap (NYSE:MDD)
Last: | $ |
---|---|
Change Percent: | |
Open: | $ |
Close: | $ |
High: | $ |
Low: | $ |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | SPDR S&P International Mid Cap (NYSE:MDD)
FREMONT, CA - ( NewMediaWire ) - November 14, 2022 - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced its financial and operating results for the third quarter of 2...
Fremont, CA - ( NewMediaWire ) - November 07, 2022 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that on October 20, 2022, it received a Notice of Allowance fo...
Message Board Posts | SPDR S&P International Mid Cap (NYSE:MDD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P International Mid Cap Company Name:
MDD Stock Symbol:
NYSE Market:
FREMONT, CA - ( NewMediaWire ) - November 14, 2022 - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced its financial and operating results for the third quarter of 2...
Fremont, CA - ( NewMediaWire ) - November 07, 2022 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that on October 20, 2022, it received a Notice of Allowance fo...
Fremont, CA - ( NewMediaWire ) - September 01, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it has filed new PCT (Patent Cooperation Treaty) applications i...